Segment Reporting - Segment and Consolidated Net Income (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jul. 03, 2026 |
Jul. 04, 2025 |
Jul. 03, 2026 |
Jul. 04, 2025 |
|
| Segment Reporting [Line Items] | ||||
| Revenues | $ 628,690 | $ 568,261 | $ 1,239,502 | $ 1,123,708 |
| Less: | ||||
| Cost of goods sold | 20,657 | 19,470 | 40,610 | 38,642 |
| Interest income | (14,210) | (16,789) | (30,337) | (35,865) |
| Provision for income taxes | 50,628 | 45,567 | 107,848 | 91,641 |
| Segment and consolidated net income | 212,050 | 184,848 | 422,517 | 344,464 |
| Reportable Segment | ||||
| Segment Reporting [Line Items] | ||||
| Revenues | 628,690 | 568,261 | 1,239,502 | 1,123,708 |
| Less: | ||||
| Cost of goods sold | 20,657 | 19,470 | 40,610 | 38,642 |
| Drug discovery | 18,252 | 21,357 | 37,728 | 39,610 |
| Development | 150,522 | 134,159 | 286,237 | 287,376 |
| Selling, general, and administrative | 127,413 | 112,931 | 250,283 | 233,706 |
| Other segment items | 63,378 | 66,718 | 124,616 | 124,134 |
| Interest income | (14,210) | (16,789) | (30,337) | (35,865) |
| Provision for income taxes | 50,628 | 45,567 | 107,848 | 91,641 |
| Segment and consolidated net income | $ 212,050 | $ 184,848 | $ 422,517 | $ 344,464 |
| X | ||||||||||
- Definition Development Expenses No definition available.
|
| X | ||||||||||
- Definition Drug Discovery Costs No definition available.
|
| X | ||||||||||
- Definition Selling, General And Administrative Expense, Excluding Separate Accounts No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|